Sep 27 |
Fortress Biotech files to sell 6.19M shares of common stock for holders
|
Sep 26 |
Fortress Biotech to Participate in October 2024 Investor Conferences
|
Sep 20 |
Why Fortress Biotech (FBIO) Stock Is Getting Hammered
|
Sep 20 |
Fortress Biotech to sell 3.9M shares at $1.65 in registered direct offering
|
Sep 20 |
Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
|
Sep 16 |
Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024
|
Sep 9 |
Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference
|
Sep 4 |
Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
Sep 4 |
Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
Sep 4 |
Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
|